Partner With TauRx

  • Home • 
  • Partner With TauRx

TauRx has a strong and defensible intellectual property position having focused for nearly 3 decades in researching tau pathology of Alzheimer’s and other neurodegenerative diseases. Professor Wischik’s team has generated a multi-layered portfolio of patents and patent applications consisting of over 836 granted patents and 120 pending. The core patents provide cover through 2032 and beyond.

Having pioneered a potential new pathway towards effective treatment and prevention of Alzheimer’s, the company’s success to date is also due to collaborations with organisations that span a variety of fields. Achieving the company’s long term vision and commercial goals will require further alliances and TauRx is pleased to consider new partnerships with organisations active in the field of neurodegeneration.

Should you match the business development interests of TauRx as outlined above please contact us.

Recent News

We’re pleased to announce the Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed acceptance of the UK Marketing Authorisation Application (MAA) for hydromethylthionine mesylate (HMTM), a 4 mg oral tablet for the treatment of mild cognitive impairment (MCI-AD) and mild to moderate Alzheimer’s disease.

Jul 29, 2024

TauRx Pharmaceuticals Ltd, a global leader in tau-based research in Alzheimer’s disease (AD), has announced the submission of a UK Marketing Authorisation Application (MAA) for hydromethylthionine mesylate (HMTM) for treatment of mild cognitive impairment (MCI-AD) and mild to moderate stages of dementia due to Alzheimer’s disease.

Jul 01, 2024

TauRx Pharmaceuticals Ltd., a global leader in tau-based research in Alzheimer’s disease (AD), presented the 24-month data from its Phase 3 LUCIDITY trial of hydromethylthionine mesylate (HMTM) at the AD/PD™ 2024 Alzheimer's & Parkinson's Diseases Conference in Lisbon, Portugal.

Mar 07, 2024

Today is the United Nations International Day of Women and Girls in Science. The day is marked every year on February 11 to ensure equal access and participation for women and girls in science.

Feb 11, 2024